doi: 10.1196/annals.1320.003 49 JonesMGoodwinCAmjadSChalmersR
A full list will be published in the patient information leaflet when the drug becomes available
Individual results may vary from those reported in clinical trials
Acting like ghrelin, ipamorelin stimulates the release of growth hormone-releasing hormone and reduces the release of somatostatin
Chemparathy DT, Ray S, Ochs C, Ferguson N, Gawande DY, Dravid SM, et al
FDA experts will first evaluate: BPC-157: used for tissue repair and to cool inflammation KPV: used to cool inflammation and boost wound healing TB-500 (Thymosin-4): used for injury recovery MOTs-C: studied for obesity and osteoporosis Emideltide (DSIP): used for insomnia and opioid withdrawal Semax: explored for neurological issues Epitalon: used for insomnia Next up, another FDA panel will review five peptides by February 2027, including: Cathelicidin (LL-37) GHK-Cu Dihexa acetate Melanotan II Mechano Growth Factor, Pegylated (PEG-MGF)